Consonance Capital Management LP / PCRX
Consonance Capital Management LP’s Pacira Biosciences Inc Position
Does Consonance Capital Management LP own Pacira Biosciences Inc (PCRX)? Not currently — the last reported position was 2.80M shares worth $122M in Q2 2019; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$122M
Q2 2019
Shares
2.80M
% of Portfolio
+8.62%
Quarters Held
2
position exited
Position History PCRX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of PCRX.